Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.
about
Immunology of Gut Mucosal VaccinesRationally designed tularemia vaccines.Identification of genes contributing to the virulence of Francisella tularensis SCHU S4 in a mouse intradermal infection modelThe immunogenic SigA enterotoxin of Shigella flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells.A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectorsA Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans.Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteersShigella isolates from the global enteric multicenter study inform vaccine development.Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity.Functional characterization of Edwardsiella tarda twin-arginine translocation system and its potential use as biological containment in live attenuated vaccine of marine fish.Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemicAntigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.Live bacterial vaccines--a review and identification of potential hazards.Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.Broadly protective Shigella vaccine based on type III secretion apparatus proteins.Live-attenuated Shigella vaccines.Use of attenuated bacteria as delivery vectors for DNA vaccines.Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.Expression of Shigella flexneri ipaB Gene in Tobacco.Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.Progress and pitfalls in Shigella vaccine research.Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidatesCharacterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes.Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine releaseShigella Vaccine Development: Finding the Path of Least Resistance.Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgRFunctional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study.An update on vaccines against Shigella.Recent progress towards development of a Shigella vaccine.Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta)Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae.How Do the Virulence Factors of Shigella Work Together to Cause Disease?Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells.Live non-invasive Shigella dysenteriae 1 strain induces homologous protective immunity in a guinea pig colitis model.T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans.A Novel Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge
P2860
Q28972559-BB30BFA5-8C10-4F1B-811E-BC18EFB6CA1BQ30436251-FB37ABD2-993F-476D-BBF1-A4CC25A610CBQ30863455-F0EAC6E8-58B6-41B5-BF6B-82C2D4378D59Q33518453-BE8D0AA8-93FA-4BA7-A185-3A7565CDAD11Q33557714-C8E02277-EE79-4898-BE58-3F03BDF0E87CQ33801151-00C7AD62-1516-4393-9DA8-F3B6079F4664Q34068059-E7B54B21-F320-41CE-BC9E-F0900584D58FQ34194587-D0FA78F8-6888-40E1-8030-55F6F8CE59F2Q34202171-DED5EFE7-6BE1-43D2-BB18-4BA526A3BBA5Q34394744-DC49B233-3ECB-4BEC-9762-8B2D29D96279Q34439836-A28F49C9-915F-499C-87EA-691B65A06EB2Q34731265-445C0079-CDCE-40C2-BBAA-FE6A53735D33Q34809879-7A7D48F2-768B-4ADB-B175-EA45BB8D9E0AQ34974711-FB1313C5-A8EA-4C7A-AE3E-3D20991A41BEQ35273267-CD1CDD3D-BE97-4770-B378-0D19ED7D2378Q35598035-AFC45E74-9D6C-42EB-B40D-2DEE9D59DA29Q35805439-39FEC746-2E9E-4B79-9A39-2EEEE452DED6Q36689023-60DFB9A3-1C9E-49D0-A678-82208BEBF169Q36728805-8B56D45C-77B5-4072-86FC-200EC9C65ADBQ36844719-25296CB1-FB11-4BEE-B262-CDA200DF8FB5Q36946812-321800B6-476F-4B81-9549-B0BDDFF6FF65Q37032264-E239E52A-0221-4B94-AF4D-925110126505Q37105553-F0270E04-DF0D-4B73-BD90-87B351C0D8EAQ37120727-5A8A00C2-BEB4-4336-A1F4-6F60E2663314Q37276296-F3039430-7453-4C15-8F1F-9EFB1A6A5947Q37458618-BDE1286D-3829-43FA-90AC-C52BD91147EEQ37477191-5209486B-FF9F-41A3-8A12-719B2B8FD163Q37483766-724D6941-3D4A-4946-B2C0-14A102BABA43Q37633069-5966E2DB-FCF1-46CF-84B6-19DFA9025563Q37668395-323D6026-2CB1-413D-ADC1-4E95B05F2C9DQ38068954-034B82DF-51FA-478A-A961-AC330CB0256BQ38294092-A389B755-5C51-4376-A7F7-6A5CCDF7800AQ38776163-54337F27-B23D-403D-84A1-F6F4D804339AQ38952300-4F7D21DB-F688-4A04-B306-210D254C50F9Q39230762-D60F1C7E-81C1-47BA-9C06-913BEDFAB1B5Q39610195-530B7FA4-FDC3-486E-8765-D7E4C5B72F8DQ50039350-12039697-7035-4DBF-BDB8-DDE936E21122Q52657631-5190EC1F-E1F0-4AFB-B4D4-3331E52BFDB2Q57929967-97A0B567-E972-47B1-8883-A68235A4757E
P2860
Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Deletion in the Shigella enter ...... rial of CVD 1204 and CVD 1208.
@en
Deletion in the Shigella enter ...... rial of CVD 1204 and CVD 1208.
@nl
type
label
Deletion in the Shigella enter ...... rial of CVD 1204 and CVD 1208.
@en
Deletion in the Shigella enter ...... rial of CVD 1204 and CVD 1208.
@nl
prefLabel
Deletion in the Shigella enter ...... rial of CVD 1204 and CVD 1208.
@en
Deletion in the Shigella enter ...... rial of CVD 1204 and CVD 1208.
@nl
P2093
P50
P356
P1476
Deletion in the Shigella enter ...... rial of CVD 1204 and CVD 1208.
@en
P2093
Eileen M Barry
Marcela F Pasetti
Marcelo B Sztein
Steven S Wasserman
William D Picking
P304
P356
10.1086/424680
P407
P577
2004-10-19T00:00:00Z